# The Drug Interaction of DWP16001 and DWC202010 After Oral Administration in Healthy Adults

> **NCT05321732** · PHASE1 · UNKNOWN · sponsor: **Daewoong Pharmaceutical Co. LTD.** · enrollment: 24 (estimated)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** DWP16001
- **DRUG:** DWP202010

## Key facts

- **NCT ID:** NCT05321732
- **Lead sponsor:** Daewoong Pharmaceutical Co. LTD.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-12-10
- **Primary completion:** 2022-08
- **Final completion:** 2022-08
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2022-04-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05321732

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05321732, "The Drug Interaction of DWP16001 and DWC202010 After Oral Administration in Healthy Adults". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT05321732. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*